YURiA-PHARM pharmaceutical company is mulling the possibility of supplying antitubercular agents to Brazil, Director General of YURiA-PHARM LLC Dmytro Derkach has said.
Currently the company is waiting for the results of the inspection of its production sites conducted by the National Agency for Sanitary Supervision of Brazil (Agencia Nacional deVigilancia Sanitaria, ANVISA), he said at a press conference at Interfax-Ukraine.
“Today Brazil is interested in products made by YURiA-PHARM, in particular these are antitubercular agents,” Derkach said.
The company seeks to continue work on the introduction of new medicine production and the implementation of the strategy to enter international markets in 2018.
“Today, our products are present in over 25 countries. Our work is being done in 50 countries,” he said.
According to Business Credit company, in January-November 2017, YURiA-PHARM was in the top three leaders in pharmacy sales in kind and it is a dynamic leader in the high price cluster.
YURiA-PHARM is a member of the Association of Manufacturers of Medications of Ukraine.
